Navigation Links
Hologic Announces Fourth Quarter Fiscal 2013 Operating Results
Date:11/11/2013

ling and marketing

76,75889,947General and administrative

47,99188,735Amortization of intangible assets

26,72624,832Contingent consideration

(465)40,399Impairment of goodwill

1,117,3695,826Acquired in-process R&D

-4,500Restructuring and divestiture charges

9,72016,6871,658,323632,251Loss from operations

(1,036,205)(43,703)Interest expense

(65,783)(56,673)Other income

3,0132,412Debt extinguishment loss

(5,962)-Loss before income taxes

(1,104,937)(97,964)Provision (benefit) for income taxes

8,965(20,197)Net loss

$
(1,113,902)$
(77,767)Net loss per common share: Basic

$
(4.11)$
(0.29)Diluted

$
(4.11)$
(0.29)Weighted average number of shares outstanding:Basic

270,867264,938Diluted

270,867264,938 

(1) Stock-based compensation included in costs and expenses during the three months ended September 28, 2013 was $1,797 for cost of revenues, $1,579 for research and development, $1,939 for selling and marketing, $3,719 for general and administrative and $1,375 for restructuring and divestiture. Stock-based compensation included in costs and expenses during the three months ended September 29, 2012 was $2,120 for cost of revenues, $1,640 for research and development, $2,121 for selling and marketing and $4,831 for general and administrative and $3,500 for restructuring. HOLOGIC, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)(In thousands, except per share data)Year EndedSeptember 28, 2013September 29, 2012REVENUES Product sales

$
2,100,891$
,657,728Service and other revenues

391,388344,9242,492,2792,002,652COSTS AND EXPENSES (1):Cost of product sales

818,160616,839Cost of product sales – amortization of intangible assets

307,895201,864Cost of product sales – impairment of intangible assets


'/>"/>
SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Hologic, Inc. Enhances Physician Training With Virtual Reality Simulation
2. FDA Approves Aptima HPV 16 18/45 Genotype Assay for Use on Hologics Panther System
3. Hologic to Host Investor Presentation at RSNA 2013
4. Hologic to Mark Start of Breast Cancer Awareness Month with NASDAQ Opening Bell Ceremony
5. Hologic to Present at Two Upcoming Investor Conferences
6. Hologic Announces Third Quarter Fiscal 2013 Operating Results
7. Hologic Announces Completion of Term Loan B Repricing
8. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
9. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
10. Hologic Appoints Jack W. Cumming President and Chief Executive Officer
11. Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologics Position as Provider of the Nations Most Comprehensive Portfolio of Interventional Breast Health Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014 A case report and ... SynCardia temporary Total Artificial Heart into a patient with ... were reversed, along with other abnormalities. ... the SynCardia Total Artificial Heart to treat a patient ... and video in the Journal of Visualized Experiments show ...
(Date:9/23/2014)... Sept. 23, 2014  Savant HWP, Inc., a ... initiation of human safety testing of 18-MC, an ... single dose of 18-MC, administered as part of ... Savant,s South American partner, was well tolerated by ... plans to develop 18-MC as a treatment for ...
(Date:9/23/2014)... BOTHELL, Wash. , Sept. 23, 2014   ... a leading developer, manufacturer and marketer of proprietary clinical ... media and precision thermal shipping products ... announced two new additions to its Scientific Advisory Board.  ... and Anthony Davies , PhD. Dr. ...
Breaking Medicine Technology:1st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 21st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 31st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 4Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7
... -- Weikang Bio-technology Group, Inc. (the "Company," "Weikang" or ... all of its management departments into the building it ... Chengde Street in the Daowai District of Harbin, the ... of the building. Mr. Yin Wang, the ...
... Dec. 27, 2011  PharmacoFore, Inc., a privately held biopharmaceutical ... equity financing from Founders Fund and the addition ... Board of Directors.   PharmacoFore uses innovative ... treating a variety of conditions related to the ...
Cached Medicine Technology:Weikang Bio-technology Group, Inc. Completes HQ Relocation After Purchasing Building for $14 Million and Answers Questions About its Third Quarter Financials 2Weikang Bio-technology Group, Inc. Completes HQ Relocation After Purchasing Building for $14 Million and Answers Questions About its Third Quarter Financials 3PharmacoFore, Inc. Secures $10 Million in Equity Financing From Founders Fund 2
(Date:9/23/2014)... 2014 (HealthDay News) -- The U.S. National Institutes ... funding in scientific trials to encourage researchers to ... The supplemental monies were provided to 82 ... immunology, cardiovascular physiology, neural circuitry, and behavioral health, ... "This funding strategy demonstrates our commitment to moving ...
(Date:9/23/2014)... Center have published the first study to extensively ... The Journal of Allergy and Clinical Immunology ... that has high levels of eosinophils in the ... allergy-associated-immune mechanisms and has a gene expression pattern ... related disorder, eosinophilic esophagitis (EoE). , Eosinophilic ...
(Date:9/23/2014)... 23, 2014) Laparoscopic cholecystectomy, a minimally invasive procedure to ... abdominal surgeries in the U.S. Yet medical centers around ... with some moving patients quickly into surgery while others ... the American Journal of Surgery , researchers found ... rather than rushing the patients into the operating room ...
(Date:9/23/2014)... Act "Obamacare" was signed into law in ... healthcare system since the 1960s. Designed to provide medical ... as an unwarranted intrusion into the affairs of private ... of healthcare systems in six Western countries, published last ... a move away from privatized medicine toward state-sponsored healthcare ...
(Date:9/23/2014)... 2014 Royal Sport Ultra Clean 100 ... LTD family of premium sports nutrition products. Its gluten ... Whey protein without artificial colors or dyes, fillers, added ... available on shelves at select GNC retailers, on GNC.com, ... is offering a limited time special on its products. ...
Breaking Medicine News(10 mins):Health News:NIH Adds $10M to Encourage Gender Balance in Clinical Trials 2Health News:Advancing the understanding of an understudied food allergy disorder 2Health News:Advancing the understanding of an understudied food allergy disorder 3Health News:Study finds gallbladder surgery can wait 2Health News:Life, liberty, and the pursuit of healthcare? 2Health News:Sports Nutrition Brand, Royal Sport LTD, Introduces 'Clean,' Gluten Free Protein Supplement, Royal Sport Ultra Clean 100™ 2
... why some of the bacteria that cause stomach ulcers ... cancer than others; it turns out these bacteria can ... the immune system. , Helicobacter pylori is a bacterial ... inflammation, ulcers, and potentially even stomach cancer. However, only ...
... LOUIS, Aug. 22 CMS, Inc., an Elekta ... workflow management,solutions, has received FDA 510(k) clearance for ... CMS to immediately,begin distributing Atlas-Based Autosegmentation for clinical ... amount of time spent creating and editing,patient contours, ...
... to launch the most sophisticated mission ever to investigate ... shape of our planet the geoid - with ... steady-state Ocean Circulation Explorer (GOCE) will be placed onto ... Rockot vehicle launched from the Plesetsk Cosmodrome in Northern ...
... But the agency says patients can still take ... News) -- U.S. drug regulators said Thursday that ... might be linked to cancer. , The U.S. ... health-care professionals that the agency was investigating a ...
... to its superior service, ... and innovative technology, FORT WORTH, Texas, Aug. 22 ... services to the retail pharmacy,industry, today announced that it ... editing and reporting services business,partner. eRx Network,s suite of ...
... halide compounds, American Elements announced today it has increased the capacity ... , ... Los Angeles, CA (PRWEB) August 22, 2008 -- ... today it has increased the capacity for U.S. based manufacturing of ...
Cached Medicine News:Health News:CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software 2Health News:GOCE Earth explorer satellite to look at the Earth's surface and core 2Health News:FDA Investigates Possible Vytorin-Cancer Link 2Health News:FDA Investigates Possible Vytorin-Cancer Link 3Health News:Kmart Pharmacy Awards Its Transaction Processing Business to eRx Network 2
A system with integrated pupil camera and 7" examination monitor. An easy to use configuration....
... Laserex Tango ophthalmic laser system provides two ... laser and a photodisruptor for posterior capsulotomy ... frequency-doubled Nd:YAG producing pulsed 532 nm light. ... 1064 nm. The appropriate laser can be ...
Extremely thin and smooth jaws, jaws open to 5.5 mm, cross action....
Flat handle cross action....
Medicine Products: